iCAD, Inc.

    iCAD, Inc.

    NNASDAQ:ICAD
    3.87
    USD
    0.00
    (0.00%)
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    TTM
    Revenue per Share
    2.62
    3.05
    3.12
    2.65
    1.65
    1.72
    1.54
    1.71
    1.34
    1.36
    0.79
    0.68
    0.74
    0.74
    Basic EPS, GAAP
    -0.87
    -0.7
    -0.07
    -2.07
    -0.63
    -0.87
    -0.54
    -0.74
    -0.8
    -0.45
    -0.54
    -0.19
    -0.21
    -0.2
    Free Cash Flow per Basic Share
    -0.46
    -0.2
    0.14
    -0.18
    -0.37
    -0.47
    -0.25
    -0.4
    -0.34
    -0.4
    -0.53
    -0.23
    -0.16
    -0.1
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -12.63
    -13.28
    -10.28
    -11.31
    -11.77
    -12.34
    -12.62
    -12.2
    -10.92
    -10.21
    -10.58
    -10.6
    -10.51
    -10.51
    Tangible Book Value per Share
    -0.8
    -1.24
    1.28
    0.91
    0.49
    0.24
    -0.18
    -0.24
    0.96
    1.51
    1.04
    0.97
    0.77
    0.84
    Basic Weighted Avg Shares
    11
    11
    14
    16
    16
    16
    17
    18
    22
    25
    25
    26
    26
    26
    Sales/Revenue/Turnover
    28
    33
    44
    42
    26
    28
    26
    31
    30
    34
    20
    17
    20
    20
    Operating Margin (%)
    -19.14
    -5.37
    1.86
    -6.34
    -37.85
    -35.52
    -31.73
    -20.41
    -31.61
    -31.9
    -51.5
    -44.4
    -31.97
    -30.5
    Depreciation Expense
    3
    2
    4
    3
    2
    1
    1
    1
    1
    1
    1
    - -
    1
    1
    Net Income, GAAP
    -9
    -8
    -1
    -32
    -10
    -14
    -9
    -14
    -18
    -11
    -14
    -5
    -6
    -5
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    -33.15
    -23.01
    -2.3
    -78.08
    -38.34
    -50.73
    -35.19
    -43.24
    -59.3
    -33.43
    -68.96
    -27.99
    -28.64
    -26.77
    Working Capital
    7
    - -
    23
    13
    7
    9
    8
    10
    26
    35
    25
    23
    19
    20
    LT Debt
    15
    12
    7
    - -
    - -
    5
    11
    17
    8
    - -
    - -
    - -
    - -
    - -
    Total Equity
    28
    21
    63
    33
    25
    14
    7
    5
    31
    47
    35
    33
    29
    31
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    USD

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    26
    26
    27
    Market Capitalization
    41
    48
    54

    Working Capital

    USD

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    Total Current Assets
    26
    26
    28
    Cash, Cash Equivalents & STI
    19
    17
    20
    Accounts Receivable, Net
    5
    7
    7
    Inventories
    1
    1
    1
    Total Current Liabilities
    6
    8
    8
    Payables & Accruals
    3
    3
    4
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    3
    4
    4

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    31.84%
    102.19%
    -14.16%
    Free Cash Flow
    -9.91%
    -3.6%
    -30.12%
    Net Income, GAAP
    306.82%
    -6.68%
    15.87%
    Sales/Revenue/Turnover
    -5.42%
    -6.48%
    13.22%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    4
    4
    4
    5
    17
    2024
    5
    5
    4
    5
    20
    2025
    5
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.15
    -0.07
    -0.05
    0.08
    -0.19
    2024
    -0.05
    -0.07
    -0.07
    -0.03
    -0.21
    2025
    -0.03
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • businesswire.com

      ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD

    • globenewswire.com

      iCAD Reports Financial Results for First Quarter Ended March 31, 2025

    • businesswire.com

      ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD

    • prnewswire.com

      $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of iCAD, Inc. - ICAD

    • businesswire.com

      ICAD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of iCad, Inc. Is Fair to Shareholders

    • globenewswire.com

      iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer

    • seekingalpha.com

      iCAD, Inc. (ICAD) Q4 2024 Earnings Call Transcript

    • globenewswire.com

      iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024

    • globenewswire.com

      iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America

    • globenewswire.com

      Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025

    • globenewswire.com

      iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025

    • globenewswire.com

      iCAD Pre-Announces Estimated Q4 2024 Revenue

    • newsfilecorp.com

      Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions

    • globenewswire.com

      SABCS 2024: New Research Assesses iCAD's Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations

    • globenewswire.com

      CORRECTION – iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024

    • globenewswire.com

      iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024

    • seekingalpha.com

      iCAD, Inc. (ICAD) Q3 2024 Earnings Call Transcript

    • globenewswire.com

      iCAD Reports Financial Results for Third Quarter Ended September 30, 2024

    • globenewswire.com

      iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference

    • newsfilecorp.com

      iCAD to Participate in the LD Micro Main Event XVII